A new international study has shown that gene therapy can significantly improve hearing in children and adults born with a specific genetic form of...
Vous n'êtes pas connecté
- NEWS.MEDICAL.NET - A la Une - 17/Jul 17:56
Specially engineered antibody delivers RNA therapy to treatment-resistant tumors
A specially engineered antibody capable of delivering RNA therapies to hard-to-reach, treatment-resistant tumors significantly shrank tumor size and improved survival in animal models, according to a study published July 16 in Science Translational Medicine.
Articles similaires
Genetic Variability Affects How Tumors Respond to Immunotherapy
wn.com - 14/Jul 05:19
From eye color to whether cilantro tastes like soap, genetic variability influences many factors in a person’s life. These inherited differences can...
Promising technologies are not yet ready to replace animal research
wn.com - 13/Jul 16:39
A recent op-ed in The Hill praising the National Institutes of Health’s new initiative to promote human-based technologies as a “major victory for...
Scientists discover protein that helps lung cancer spread to the brain
oncologynews.com.au - 08/Jul 14:42
Researchers at McMaster University, Cleveland Clinic, and Case Comprehensive Cancer Centre, USA, have uncovered how a protein long associated with...
Scientists discover protein that helps lung cancer spread to the brain
oncologynews.com.au - 08/Jul 14:42
Researchers at McMaster University, Cleveland Clinic, and Case Comprehensive Cancer Centre, USA, have uncovered how a protein long associated with...
Autologous Cell Therapy Product Market: Innovations, Growth Outlook, and Regional Focus on North America
wn.com - 15/Jul 07:22
Overview of Autologous Cell Therapy Product Market Global Cell Therapy Market is valued at USD 10.1 Billion in 2025 and is projected to attain a value...
Autologous Cell Therapy Product Market: Innovations, Growth Outlook, and Regional Focus on North America
wn.com - 15/Jul 07:22
Overview of Autologous Cell Therapy Product Market Global Cell Therapy Market is valued at USD 10.1 Billion in 2025 and is projected to attain a value...
FDA Grants Fast Track Designation for TRE-515 in Combination with Radiation Therapy for the Treatment of Metastatic Castration Resistant Prostate Cancer
drugs.com - 09/Jul 06:07
Los Angeles, July 9, 2025 — Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class...
ASX biotechs join global race for cell therapy breakthroughs
stockhead.com.au - 08/Jul 20:00
Several ASX-listed biotechs are advancing cell therapies to capture a share of a global market projected to reach US$48 billion ...
Leukocyte Adhesion Deficiency Market Poised for Steady Growth Through 2034, Driven by Gene Therapy Advancements ...
wn.com - 17/Jul 22:01
"Leukocyte Adhesion Deficiency Market Insight, Epidemiology and Market Forecast - 2034" The leukocyte adhesion deficiency market is experiencing...
Les derniers communiqués
-
Aucun élément